Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Efficacy of Hepatic T2∗ Mri Values and Serum Ferritin Concentration in Predicting Thalassemia Major Classification for Hematopoietic Stem Cell Transplantation Publisher Pubmed



Hamidieh AA1 ; Moeininia F2 ; Tayebi S1 ; Shamshiri AR3 ; Behfar M1 ; Jalili M1 ; Alimoghaddam K1 ; Ghavamzadeh A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Internal Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
  3. 3. Dental Research Center, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran

Source: Pediatric Transplantation Published:2015


Abstract

Liver biopsy has been performed for many decades for classifying the patients with TM. Meanwhile, using non-invasive methods such as T2∗ MRI technique has been recently much more considered to determine the hepatic iron overload. Ninety-three pediatric HSCT candidates with TM who underwent liver biopsy were included in this study. Hepatic T2∗ MRI values and serum ferritin concentrations were assessed to investigate and determine the useful method in detection of patients with TM class III whom received different conditioning regimens, in comparison with class I and II. Twenty (21.5%) patients were categorized as class III. Hepatic T2∗ MRI could detect TM class III patients with 60% sensitivity and 87.67% specificity (LR+: 4.867, accuracy: 81.72%), while predictive feature of ferritin values for distinguishing patients with TM class III was not statistically significant (p-value >0.01). Combination of T2∗MRI with age (T2∗-age) could detect TM class III with 85% sensitivity and 72.6% specificity (LR+: 3.1, accuracy: 75.27%).T2∗-age may be considered as an alternative and non-invasive method to liver biopsy for differentiation and classification of patients with TM before transplantation. © 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
6. Long--Term Free Survival of Two Class Iii Β-Thalassemic Patients After Non-Myeloablative Stem Cell Transplantation, International Journal of Hematology-Oncology and Stem Cell Research (2020)
Experts (# of related papers)
Other Related Docs